Citations

Mayo Clinic

Showing 10 of 108522 citations.

ELECTROCHEMICAL RECORDINGS DURING DEEP BRAIN STIMULATION IN ANIMALS AND HUMANS: WINCS, MINCS, AND CLOSED-LOOP DBS
Chang, Su-Youne , Bennet, Kevin E. , Lee, Kendall H. , Blaha, Charles D.

Compendium of In Vivo Monitoring in Real-Time Molecular Neuroscience | December 19, 2014 | Volume: No volume available | Issue: No issue available | Pages: 225-250

10.1142/9789814619776_0010 Get It

Pharmacogenetics of Inflammatory Bowel Disease
Papadakis, Konstantinos A. , Katsanos, Konstantinos H.

Pharmacogenomics | December 19, 2014 | Volume: 15 | Issue: 16 | Pages: 2049-2062

10.2217/pgs.14.154 | PMID 25521361 Get It

Postencephalitic epilepsy: Clinical characteristics and predictors
Singh, Tarun D. , Fugate, Jennifer E. , Hocker, Sara E. , Rabinstein, Alejandro A.

Epilepsia | December 19, 2014 | Volume: 56 | Issue: 1 | Pages: 133-138

10.1111/epi.12879 | PMID 25523929 Get It

Summary Objective To describe the etiologies, clinical presentations, outcomes, and predictors of postencephalitic epilepsy ( PE ) in a large series of adult patients with acute encephalitis. Methods We conducted a retrospective review of patients diagnosed with acute encephalitis at Mayo Clinic, Rochester, between January 2000 and December 2012. The patients were categorized into two groups based on the presence or absence of PE at last follow‐up. Multivariate logistic regression analysis was used to analyze factors associated with PE . Results We identified 198 consecutive patients (100 [50.5%] male and 98 [49.5%] female) with a median age of 58 years (range 41.8–69). Etiologies included viral infection (n = 95, 48%), autoimmune (n = 44, 22%), and unknown/others (n = 59, 30%). During hospitalization, seizures were seen in patients with autoimmune encephalitis (n = 24, 54.5%), unknown/others (n = 20, 33.9%), and viral encephalitis (n = 23, 24.2%). Interictal epileptiform discharges on electroencephalography (EEG) were present in 34 (54%), whereas periodic lateralized epileptiform discharges (PLEDs) and generalized periodic discharges (GPDs) were seen in 14 (41.2%) and 2 (5.9%) patients. Forty‐six patients with seizures (70.8%) had fluid‐attenuated inversion recovery ( FLAIR )/T 2 abnormalities, 20 (31.3%) diffusion abnormalities, and 43 (66.2%) cortical involvement. Good outcome at discharge among patients with seizures was seen in 8/23 patients with viral etiology (34.8%), 10/24 patients with autoimmune encephalitis (45.5%), and 12/20 patients with unknown cause (60%). PE was present in 43 patients (29.9%). On multivariate regression analysis, the factors associated with PE were generalized seizures during hospitalization (p = 0.03), focal seizures (p ≤ 0.001), and the presence of FLAIR /T 2 abnormalities on brain magnetic resonance imaging ( MRI ) (p = 0.003). Significance The presence of seizures during hospitalization and an abnormal brain MRI are the strongest predictors of the development of PE . The etiology of encephalitis, presence of focal neurologic deficits, and interictal EEG abnormalities did not influence the development of PE .
Prospective series of two hours supine rest after 4fr sheath-based diagnostic cerebral angiography: Outcomes, productivity and cost
Bhatia, Ritwik , Tsujiara, Crystiana, Baker, Christopher B. , Szafran, Alex, Cushing, Deborah, Aiken, Judy, Tracy, Marilyn, Ecker, Robert D., Zuckerman, Scott L. , Mocco, J

Interventional Neuroradiology | December 19, 2014 | Volume: 21 | Issue: 1 | Pages: 114-119

10.15274/inr-2014-10102 | PMID 25934785 Get It

There is no standard of care for catheter size or post-procedure supine time in cerebral angiography. Catheter sizes range from 4-Fr to 6-Fr with supine times ranging from two to over six hours. The objective of our study was to establish the efficacy, safety, and cost savings of two-hour supine time after 4-Fr elective cerebral angiography. A prospective, single arm study was performed on 107 patients undergoing elective cerebral angiography. All cerebral angiograms were performed with a 4-Fr sheath-based system without closure devices. Ten minutes of manual compression was applied to the femoral access site, with further compression held as clinically indicated. Patients were then monitored in a nursing unit for two hours supine and subsequently mobilized. Nursing discretion was allowed for earlier mobilization. Patients were called the next day to assess delayed hematoma and bleeding. Estimates of cost savings and productivity increases are provided. All patients ambulated in two hours or less. There were no strokes or vessel dissections. Five patients (4.7%) experienced a palpable hematoma, three patients (2.8%) experienced bleeding immediately following the procedure requiring further compression, and one patient (0.9%) experienced minor groin oozing at home. No patient required transfusion, thrombin injection, or endovascular/surgical management of a groin complication. A two-hour post-procedure supine time resulted in cost savings of $952 per angiogram and a total of $101,864. 4-Fr sheath based cerebral angiography with two-hour post-procedure supine time is safe and effective, and allows for a considerable increase in patient satisfaction, cost savings and productivity.
A compendium of cytogenetic abnormalities in myelofibrosis: molecular and phenotypic correlates in 826 patients
Wassie, Emnet A, Finke, Christy M. , Gangat, Naseema , Pardanani, Animesh , Hanson, Curtis A. , Ketterling, Rhett P. , Tefferi, Ayalew , Wassie, Emnet, Lasho, Terra L. , Ketterling, Rhett P

British Journal of Haematology | December 19, 2014 | Volume: 169 | Issue: 1 | Pages: 71-76

10.1111/bjh.13260 | PMID 25521305 Get It

SummaryAmong 826 patients with primary myelofibrosis (PMF) and analysable metaphases on cytogenetic studies, 352 (42·6%) had abnormal karyotype, of which 240 (68·2%) were sole aberrations and 48 (13·6%) were complex; the most frequent abnormalities were 20q− (23·3%), 13q− (18·2%), +8 (11·1%), +9 (9·9%), chromosome 1q+ (9·7%) and −7/7q− (7·1%). Phenotypic correlates included: abnormal karyotype with anaemia (P = 0·02), leucopenia (P < 0·01) and thrombocytopenia (P < 0·01); complex karyotype with younger age (P = 0·04) and thrombocytopenia (P < 0·01); leucopenia with 20q−, +8 and −7/7q− and thrombocytopenia with 20q− and −7/7q−. Cytopenias were less likely to occur with 13q−. 476 patients were annotated for JAK2/CALR/MPL mutations; abnormal karyotype frequencies were 43% in JAK2, 42% CALR, 33% MPL mutated and 34% triple‐negative cases (P = 0·3). A proportion of patients were also screened for ASXL1, EZH2, IDH1, IDH2, SRSF2, U2AF1 and SF3B1 mutations; in all instances, mutational frequencies were higher in patients with normal karyotype, reaching significance for ASXL1 (P = 0·02) and U2AF1 (P = 0·01). 13q− was associated with mutant CALR (P = 0·03), +9 with mutant JAK2 (P = 0·02) and 20q− with mutant SRSF2 (P = 0·02). The current PMF study provides detailed cytogenetic information and correlations with mutations and clinical phenotype.
Screening for celiac disease in the general population and in high‐risk groups
Card, Tim , Kaukinen, Katri , Bai, Julio C. , Zingone, Fabiana , Sanders, David S. , Ludvigsson, Jonas F. , Murray, Joseph A.

United European Gastroenterology Journal | December 19, 2014 | Volume: 3 | Issue: 2 | Pages: 106-120

10.1177/2050640614561668 | PMID 25922671 Get It

Background Celiac disease (CD) occurs in approximately 1% of the Western population. It is a lifelong disorder that is associated with impaired quality of life (QOL) and an excessive risk of comorbidity and death. Objectives To review the literature on screening for CD in relation to the current World Health Organization (WHO) criteria for mass screening. Methods We performed a PubMed search to identify indexed papers on CD screening with a publication date from 1900 until 1 June 2014. When we deemed an abstract relevant, we read the corresponding paper in detail. Results CD fulfills several WHO criteria for mass screening (high prevalence, available treatment and difficult clinical detection), but it has not yet been established that treatment of asymptomatic CD may reduce the excessive risk of severe complications, leading to higher QOL nor that it is cost‐effective. Conclusions Current evidence is not sufficient to support mass screening for CD, but active case‐finding may be appropriate, as we recognize that most patients with CD will still be missed by this strategy. Although proof of benefit is still lacking, screening for CD may be appropriate in high‐risk groups.
Chronically endurance-trained individuals preserve skeletal muscle mitochondrial gene expression with age but differences within age groups remain
Lanza, Ian R. , Short, Daniel K., Asmann, Yan W. , Johnson, Matthew L. , Nair, K. Sreekumaran , Lanza, Ian R

Physiological Reports | December 19, 2014 | Volume: 2 | Issue: 12 | Pages: e12239

10.14814/phy2.12239 | PMID 25524277 Get It

Removal of floating inferior vena cava thrombus with the AngioVac device
Johnson, Angela, Bjarnason, Haraldur , Shields, Raymond C., Shih, Henry, McBane, Robert D. , Martino, Randall R. De , Johnson, Angela M, De Martino, Randall R, McBane, Robert , Bjarnason, Haraldur

Vascular Medicine | December 18, 2014 | Volume: 20 | Issue: 2 | Pages: 190-192

10.1177/1358863x14562659 | PMID 25520317 Get It

A Review of Child and Adolescent Diagnostic Interviews for Clinical Practitioners
Leffler, Jarrod M. , Riebel, Jordanna, Hughes, Honore M.

Assessment | December 18, 2014 | Volume: 22 | Issue: 6 | Pages: 690-703

10.1177/1073191114561253 | PMID 25520212 Get It

The publication of the DSM-5 poses a challenge for many interview instruments due to the changes for many of the diagnoses. Six of the more widely used and studied interview instruments (structured and semistructured) were reviewed with a focus on usefulness for the practicing clinician and researcher. Use of these types of assessment procedures can facilitate the accuracy of diagnoses given by potentially reducing clinician bias. Each interview instrument varied in its strengths and characteristics related to amount of flexibility associated with administration of items; breadth of coverage of diagnoses based on DSM-IV; time required for administration; presence of screening items or modular format; and psychometric support for its reliability and validity, as well as amount of training required for use, and costs associated with acquiring and learning the format. Recommendations were made regarding the utilization of different instruments for specific diagnostic questions along with future recommendations for enhancing the format and utility of these instruments, especially in relation to the publication of the DSM-5.
Aspirin, NSAIDs, and Risk of Prostate Cancer: Results from the REDUCE Study
Vidal, Adriana C. , Moreira, Daniel M. , Castro‐Santamaria, Ramiro , Andriole, Gerald L. , Freedland, Stephen J. , Howard, Lauren E.

Clinical Cancer Research | December 18, 2014 | Volume: 21 | Issue: 4 | Pages: 756-762

10.1158/1078-0432.ccr-14-2235 | PMID 25520389 Get It

Abstract Purpose: A recent meta-analysis showed that aspirin was associated with reduced prostate cancer risk. As anti-inflammatory medications lower PSA levels, whether these findings reflect reduced prostate cancer detection or lower prostate cancer risk is unknown. We tested the association between aspirin and nonaspirin NSAID use on prostate cancer diagnosis in REDUCE, where all men received biopsies at 2 and 4 years largely independent of PSA. REDUCE tested dutasteride for prostate cancer risk reduction in men with a PSA of 2.5 to 10.0 ng/mL and a negative prestudy biopsy. Experimental Design: We examined the association between aspirin, NSAIDs, or both and total, low-grade (Gleason &lt; 7), or high-grade (Gleason ≥ 7) prostate cancer versus no prostate cancer using multinomial logistic regression among 6,390 men who underwent ≥1 on-study biopsy. Multivariable analyses were adjusted for age, race, geographic region, PSA, prostate volume, digital rectal examination, body mass index, treatment arm, smoking, alcohol, statins, hypertension, diabetes, and cardiovascular disease. Results: Overall, 3,169 men (50%) were nonusers, 1,368 (21%) used aspirin, 1,176 (18%) used NSAIDs, and 677 (11%) used both. In unadjusted models, aspirin was associated with reduced prostate cancer risk (OR = 0.85, P = 0.036). In multivariable analyses, aspirin was associated with reduced total prostate cancer risk (OR = 0.81, P = 0.015). Use of NSAIDs or NSAIDs and aspirin was not associated with total, low-grade, or high-grade prostate cancer, though all ORs were &lt;1 (all P ≥ 0.08). Therefore, we created a dichotomous variable of aspirin and/or NSAID users versus nonusers. On multivariable analysis, the use of aspirin and/or NSAIDs was significantly associated with decreased total (OR = 0.87, P = 0.030) and high-grade (OR = 0.80, P = 0.040), but not with low-grade, prostate cancer risk (OR = 0.90, P = 0.15). Results were similar in placebo and dutasteride arms. Conclusions: Among men with a negative biopsy, aspirin and/or NSAID use was associated with decreased prostate cancer risk. Additional studies are warranted. Clin Cancer Res; 21(4); 756–62. ©2014 AACR.